NOV (NOV) director increases stake with November share purchases

Rhea-AI Filing Summary

NOV Inc. (NOV) reported an insider stock purchase by a director. On 11/21/2025, the director bought 20,000 shares of NOV common stock at $14.36 per share and another 50,000 shares at $14.50 per share. Following these open-market purchases, the director beneficially owned 85,949 NOV common shares held directly.

Insights

Equity Compensation and Governance Analyst

Director made sizeable open-market share purchases, increasing direct ownership and economic alignment with common shareholders.

The filing shows a director of NOV Inc. buying common stock in two open-market transactions on 11/21/2025. The purchases were for 20,000 shares at $14.36 and 50,000 shares at $14.50, for a total of 70,000 shares acquired. After these trades, the director directly owns 85,949 common shares, and no derivative securities are reported in Table II.

These are purchases coded "P" and marked as “A” (acquired), which indicates buying rather than selling. The increase in direct holdings can strengthen perceived alignment between board oversight and shareholder outcomes, since a larger portion of the director’s personal wealth now tracks NOV’s equity performance. There is no indication in this filing of any related derivatives, hedging, or complex structures that might offset this exposure.

Items to watch include whether these purchases are part of any disclosed Rule 10b5-1 trading plan and whether similar open-market buying appears in subsequent Forms 4 by this or other insiders. Monitoring future ownership changes after 11/21/2025 can help build a picture of whether this is an isolated transaction or part of a broader pattern of insider accumulation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kendall Christian S

(Last) (First) (Middle)

10353 RICHMOND AVE.

(Street)

HOUSTON 77042

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NOV Inc. [ NOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/21/2025		P		20,000	A	$14.36	35,949	D
Common Stock	11/21/2025		P		50,000	A	$14.5	85,949	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: Peter F. Vranderic For: Christian S. Kendall	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NOV (NOV) disclose in this Form 4?

The filing discloses that a NOV Inc. director purchased NOV common stock in open-market transactions on 11/21/2025.

How many NOV shares did the director purchase and at what prices?

The director bought 20,000 NOV common shares at $14.36 per share and 50,000 shares at $14.50 per share.

What is the directors total NOV share ownership after these trades?

After the reported purchases, the director beneficially owned 85,949 NOV common shares held directly.

What is the reporting persons relationship to NOV Inc.?

The reporting person is identified as a Director of NOV Inc.

Were any derivative securities, such as options or warrants, reported for NOV in this Form 4?

The table for derivative securities is present but shows no derivative transactions or holdings reported for this director.

Is this NOV Form 4 filed for one person or multiple reporting persons?

The form is indicated as filed by one reporting person, not a group filing.